It remains critical to assist men in making informed decisions regarding screening for prostate cancer, because of the conflicting recommendations for screening and the mixed messages about its effectiveness, they added.
This study was supported by the National Cancer Institute, the Department of Defense, and the Lombardi Comprehensive Cancer Center. No financial conflicts of interest were reported.